Skip to content
PawLabel
United Kingdom — VMD

Mirataz 20 mg/ml Transdermal Ointment for Cats

Authorised animal medicine, recorded in United Kingdom — VMD. This is a neutral reference record and does not provide dosing or veterinary advice.
Reference information only — not veterinary advice and not a dosing source. Always consult a licensed veterinarian before giving any medicine to an animal.

Active substances

Target species

cats

Authorisation

No. EU/2/19/247/003 · POM-V · Neurological Agent behavioural

Source

United Kingdom — VMD. Original source.

Other Mirtazapine medicines

Reported adverse events (openFDA)

Spontaneous adverse-event reports that name Mirtazapine, by species — reported counts, not proven reactions.

Cat

1,749 reported events

openFDA

Top reactions: Lack of efficacy - NOS (260) · Death by euthanasia (229) · Vomiting (215) · Weight loss (176) · Not eating (153)

Source: openFDA Animal & Veterinary adverse-event reports.

Surveillance reference only — these are spontaneous adverse-event report counts, not proven adverse reactions, not causation and not a measure of any product's risk or safety. Always consult a licensed veterinarian.

Explore